Gene set analysis of purine and pyrimidine antimetabolites cancer therapies (Q38690391)

5 September 2017

Gene set analysis of purine and pyrimidine antimetabolites cancer therapies (English)

1 reference

5 September 2017

9

Richard M Weinshilboum

1 reference

5 September 2017

2

Anthony Batzler

1 reference

5 September 2017

5

Alice Matimba

1 reference

5 September 2017

1

Brooke L Fridley

1 reference

5 September 2017

Liang Li

3

1 reference

5 September 2017

Fang Li

4

1 reference

5 September 2017

Gregory D Jenkins

6

1 reference

5 September 2017

Yuan Ji

7

1 reference

5 September 2017

Liewei Wang

8

1 reference

5 September 2017

1 November 2011

1 reference

Pharmacogenetics and Genomics

5 September 2017

1 reference

5 September 2017

21

1 reference

5 September 2017

11

1 reference

5 September 2017

701-712

1 reference

Self-contained gene-set analysis of expression data: an evaluation of existing and novel methods

5 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Ecto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Identification of survival genes in human glioblastoma cells by small interfering RNA screening

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Proteasome regulators: activators and inhibitors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Analyzing gene expression data in terms of gene sets: methodological issues

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Cellular pharmacology of gemcitabine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: Review of three randomized trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Microarray data analysis: from disarray to consolidation and consensus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

A global test for groups of genes: testing association with a clinical outcome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysis,

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Role of MRP4 and MRP5 in biology and chemotherapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Identification of cyclic AMP-phosphodiesterase variants from the PDE4D gene expressed in human peripheral mononuclear cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

The clinical pharmacology of 6-mercaptopurine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

A genomic approach to identify molecular pathways associated with chemotherapy resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

In focus: advanced pancreatic cancer.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192305

[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases]

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21869733

12 December 2020

inferred from PubMed ID database lookup

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21869733

12 December 2020

inferred from PubMed ID database lookup

Linking oncogenic pathways with therapeutic opportunities

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21869733

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1097/FPC.0B013E32834A48A9

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rbda4m5hm5f6tel7nu4ilixeni

30 July 2022

release_rbda4m5hm5f6tel7nu4ilixeni

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rbda4m5hm5f6tel7nu4ilixeni

30 July 2022

https://api.fatcat.wiki/v0/release/rbda4m5hm5f6tel7nu4ilixeni

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/rbda4m5hm5f6tel7nu4ilixeni

1 reference

30 July 2022